Alterity Therapeutics Limited (ASX:ATH)

Alterity Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	49.2	33.16	12.64	15.77	34.81	28.12
Short-Term Investments	-	7.5	-	-	-	-
Cash & Short-Term Investments	49.2	40.66	12.64	15.77	34.81	28.12
Cash Growth	21.01%	221.70%	-19.87%	-54.68%	23.80%	205.71%
Accounts Receivable	6.73	3.93	4.02	8.65	4.67	4.13
Other Receivables	0.11	0.01	0.02	0.02	0.06	0.15
Receivables	6.84	3.94	4.04	8.67	4.73	4.28
Prepaid Expenses	-	1.23	2.32	2.57	1.6	1.09
Other Current Assets	0.78	0.04	0.04	0.04	0.01	0.01
Total Current Assets	56.82	45.87	19.04	27.05	41.14	33.49
Property, Plant & Equipment	0.1	0.16	0.19	0.27	0.22	0.1
Total Assets	56.92	46.03	19.22	27.32	41.36	33.59

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	1.6	0.54	0.58	1.72	2.66	1.45
Accrued Expenses	0.94	2.89	4.56	2.5	3.02	1.56
Current Portion of Leases	0.03	0.07	0.11	0.11	0.06	0.03
Current Income Taxes Payable	0.02	0.02	0.02	0.03	0.03	-
Other Current Liabilities	0	0.02	0.11	0.03	0.06	0.03
Total Current Liabilities	2.59	3.53	5.37	4.38	5.82	3.07
Long-Term Leases	0.07	0.09	0.05	0.1	0.06	0.04
Other Long-Term Liabilities	-	-	-	0.02	0.01	0.01
Total Liabilities	2.65	3.62	5.43	4.5	5.89	3.12

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	282.51	262.95	223.15	213.97	213.79	197.45
Retained Earnings	-234.38	-225.89	-214.16	-195.13	-181.88	-169.73
Comprehensive Income & Other	6.13	5.34	4.81	3.97	3.57	2.75
Shareholders' Equity	54.27	42.4	13.8	22.81	35.47	30.47
Total Liabilities & Equity	56.92	46.03	19.22	27.32	41.36	33.59

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	0.1	0.16	0.16	0.21	0.12	0.07
Net Cash (Debt)	49.1	40.5	12.48	15.56	34.69	28.05
Net Cash Growth	21.23%	224.55%	-19.81%	-55.13%	23.67%	206.12%
Net Cash Per Share	0.28	0.32	0.17	0.32	0.72	0.83
Filing Date Shares Outstanding	217.51	184.17	106.41	48.8	48.14	48.14
Total Common Shares Outstanding	217.51	182.55	104.9	48.8	48.14	41.68
Working Capital	54.24	42.34	13.66	22.67	35.32	30.42
Book Value Per Share	0.25	0.23	0.13	0.47	0.74	0.73
Tangible Book Value	54.27	42.4	13.8	22.81	35.47	30.47
Tangible Book Value Per Share	0.25	0.23	0.13	0.47	0.74	0.73

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 28, 2026

Data Sources Report a data error